MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-026-57988-z

Медицинская библиотека · Scientific reports · 2026

Serotype-specific neutralizing activity and clinical outcomes associated with intravenous immunoglobulin in pediatric HAdV-3 and HAdV-7 infections.

Yang Zhongying, Huang Yanhao, Fang Heping, Rao Lifen, Lu Ying, Liu Xiangyu, Wei Jianhua, Liao Jing, Ren Luo, Liu Enmei, Zang Na

СтатьяПеревод в очереди

Аннотация

Human adenovirus (HAdV) is an important cause of pediatric acute respiratory infection and severe pneumonia, with HAdV-3 and HAdV-7 being predominant respiratory serotypes. Intravenous immunoglobulin (IVIG) is empirically used in severe HAdV infection, but its serotype-specific activity remains unclear. In this retrospective clinical and in vitro study, 365 children with PCR-positive HAdV infection were screened, and 313 children with HAdV-3 or HAdV-7 detection were characterized, including 174 HAdV-3 and 139 HAdV-7 cases. HAdV-7 was associated with a higher proportion of severe disease than HAdV-3 (37.41% vs. 19.54%). The core clinical analysis focused on patients stratified by serotype and IVIG administration, including 82 IVIG-treated patients: 27 with HAdV-3 and 55 with HAdV-7. Among IVIG-treated patients, HAdV-3 cases showed shorter times to fever normalization and respiratory symptom resolution than HAdV-7 cases, although these observations should be interpreted cautiously. In vitro, commercial IVIG products showed stronger neutralizing activity against HAdV-3 than HAdV-7, with peak titers of > 1:1024 versus 1:256. IVIG also provided greater improvement in cell viability in HAdV-3-infected cells than in HAdV-7-infected cells (12.02% vs. 8.87%), more strongly reduced viral attachment (75.75% vs. 58.43%), and markedly inhibited HAdV-3 internalization. These findings suggest serotype-specific differences in IVIG antiviral activity and support prospective evaluation of serotype-guided IVIG strategies.

Для цитирования: Yang Zhongying, Huang Yanhao, Fang Heping, Rao Lifen, Lu Ying, Liu Xiangyu, Wei Jianhua, Liao Jing, Ren Luo, Liu Enmei, Zang Na. Serotype-specific neutralizing activity and clinical outcomes associated with intravenous immunoglobulin in pediatric HAdV-3 and HAdV-7 infections.. Scientific reports. 2026. DOI: 10.1038/s41598-026-57988-z.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.